Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Inflammation × Tumor Necrosis Factors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Hypertension 1

Interventions

Omeprazole 2 soybean oil, phospholipid emulsion 1 dolutegravir 1 Vitamin D 1 Tumor Necrosis Factors 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Sufentanil 1 Sodium Chloride 1 Ritonavir 1 Riluzole 1 Oxycodone 1 Nutrition Assessment 1 Nucleosides 1 Naproxen 1 Infliximab 1 Fish Oils 1 Febuxostat 1 Exercise 1 Diet 1 Dexlansoprazole 1 Darunavir 1 Colchicine 1 Clindamycin 1 ClinOleic 1 Cephalexin 1 Anti-Bacterial Agents 1 Allopurinol 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡